City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border 		  
  PROFILE 
The following is a list of available studies directed by  John Zaia, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
 
Click here to generate a printer-friendly view  
 03161
   P.I.: John Zaia, MD (Institutional)
Title: A Pilot Study of Safety and Feasibility of T-Cell Immunotherapy Using Lentivirus Vector-Expressed RNAi in Autologous T-Cells of HIV-1 Infected Patients Who Have Failed Anti-Retroviral Therapy
 
Click here for  Full Eligibility Criteria
 03121
   P.I.: John Zaia, MD (NCI Approved External Peer Review)
Title: A Phase I Dose Escalation Study of Peptide Vaccines with Activity Against Human Cytomegalovirus
 
Click here for  Full Eligibility Criteria
 02025
   P.I.: John Zaia, MD (Institutional)
Title: Long-Term Follow Up of Recipients of Gene Transfer Research at City of Hope
 

  
© 2009 City of Hope.
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673)
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.